March 27, 2017
MDxHealth’s biomarkers for Prostate Cancer test could be used for the aggressive version of the disease
MDxHealth has reported results from a castration resistant prostate cancer (CRPC) treatment study.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: castration resistant prostate cancer